XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 29, 2018
Sep. 30, 2017
Sep. 29, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Net sales $ 3,279,678 $ 3,161,083 $ 9,826,793 $ 9,143,489
Cost of sales 2,391,118 2,325,029 7,141,569 6,645,342
Gross profit 888,560 836,054 2,685,224 2,498,147
Operating expenses:        
Selling, general and administrative 668,011 622,506 2,027,138 1,874,644
Litigation settlements 38,488 0 38,488 5,325
Transaction costs related to Animal Health spin-off 7,282 0 18,670 0
Restructuring costs 8,853 0 27,511 0
Operating income 165,926 213,548 573,417 618,178
Other income (expense):        
Interest income 5,163 4,793 15,429 13,204
Interest expense (21,045) (13,428) (56,466) (37,056)
Other, net (346) (194) (802) 489
Income before taxes and equity in earnings of affiliates 149,698 204,719 531,578 594,815
Income taxes (29,401) (59,340) (124,084) (156,276)
Equity in earnings of affiliates 6,679 5,569 15,622 12,244
Net income 126,976 150,948 423,116 450,783
Less: Net income attributable to noncontrolling interests (5,498) (12,917) (20,208) (35,949)
Net income attributable to Henry Schein, Inc. $ 121,478 $ 138,031 $ 402,908 $ 414,834
Earnings per share attributable to Henry Schein, Inc.:        
Basic (in dollars per share) $ 0.8 $ 0.88 $ 2.63 $ 2.64
Diluted (in dollars per share) $ 0.79 $ 0.87 $ 2.62 $ 2.61
Weighted-average common shares outstanding:        
Basic (in shares) 152,533 156,914 152,970 157,386
Diluted (in shares) 153,614 158,271 153,982 158,866